Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
INTERPACE BIOSCIENCES, INC.
| Metric | INTERPACE BIOSCIENCES, INC. IDXGHealthcare |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $39M |
| Net income (latest) | $25M |
| Operating margin | 10.5% |
| Net margin | 63.5% |
| Return on equity | 109.9% |
| Return on assets | 72.6% |
| Return on capital (ROCE) | 14.2% |
| Debt / equity | 0.51× |
| Revenue growth (YoY) | 280.5% |
| Altman Z″ (distress) | -16.52 |
| Accruals / assets | 55.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.